MAL overexpression leads to disturbed expression of genes that influence cytoskeletal organization and differentiation of Schwann cells

ASN Neuro. 2014 Sep 10;6(5):1759091414548916. doi: 10.1177/1759091414548916. Print 2014.

Abstract

In the developing peripheral nervous system, a coordinated reciprocal signaling between Schwann cells and axons is crucial for accurate myelination. The myelin and lymphocyte protein MAL is a component of lipid rafts that is important for targeting proteins and lipids to distinct domains. MAL overexpression impedes peripheral myelinogenesis, which is evident by a delayed onset of myelination and reduced expression of the myelin protein zero (Mpz/P0) and the low-affinity neurotrophin receptor p75(NTR). This study shows that MAL overexpression leads to a significant reduction of Mpz and p75(NTR) expression in primary mouse Schwann cell cultures, which was already evident before differentiation, implicating an effect of MAL in early Schwann cell development. Their transcription was robustly reduced, despite normal expression of essential transcription factors and receptors. Further, the cAMP response element-binding protein (CREB) and phosphoinositide 3-kinase signaling pathways important for Schwann cell differentiation were correctly induced, highlighting that other so far unknown rate limiting factors do exist. We identified novel genes expressed by Schwann cells in a MAL-dependent manner in vivo and in vitro. A number of those, including S100a4, RhoU and Krt23, are implicated in cytoskeletal organization and plasma membrane dynamics. We showed that S100a4 is predominantly expressed by nonmyelinating Schwann cells, whereas RhoU was localized within myelin membranes, and Krt23 was detected in nonmyelinating as well as in myelinating Schwann cells. Their differential expression during early peripheral nerve development further underlines their possible role in influencing Schwann cell differentiation and myelination.

Keywords: Schwann cell development; Schwann cell differentiation; cytoskeleton; myelin and lymphocyte protein (MAL); peripheral nerve myelination.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / pharmacology
  • Animals
  • Animals, Newborn
  • Cell Differentiation / drug effects
  • Cell Differentiation / genetics*
  • Cells, Cultured
  • Colforsin / pharmacology
  • Cytoskeleton / metabolism*
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / genetics
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Myelin P0 Protein / genetics
  • Myelin P0 Protein / metabolism
  • Myelin and Lymphocyte-Associated Proteolipid Proteins / genetics
  • Myelin and Lymphocyte-Associated Proteolipid Proteins / metabolism*
  • Oncogene Protein v-akt / genetics
  • Oncogene Protein v-akt / metabolism
  • Phosphatidylinositol 3-Kinases / metabolism
  • Receptors, Nerve Growth Factor / genetics
  • Receptors, Nerve Growth Factor / metabolism
  • S100 Calcium-Binding Protein A4
  • S100 Proteins / genetics
  • S100 Proteins / metabolism
  • Schwann Cells / drug effects
  • Schwann Cells / metabolism*
  • Sciatic Nerve / cytology
  • Signal Transduction / drug effects
  • Signal Transduction / genetics

Substances

  • Adjuvants, Immunologic
  • Mal protein, mouse
  • Mpz protein, mouse
  • Myelin P0 Protein
  • Myelin and Lymphocyte-Associated Proteolipid Proteins
  • Receptors, Nerve Growth Factor
  • S100 Calcium-Binding Protein A4
  • S100 Proteins
  • S100a4 protein, mouse
  • Ngfr protein, mouse
  • Colforsin
  • Phosphatidylinositol 3-Kinases
  • Oncogene Protein v-akt